Serologic prevalence of coxsackievirus group B in Greece

Viral Immunology

Volumn 20, Issue 1, 2007, Pages 11-18

  Mavrouli, M D ^a   Spanakis, N ^a   Levidiotou, S ^b   Politi, C ^c   Alexiou, S ^d   Tseliou, P ^e   Hatzitaki, M ^f   Foundouli, K ^g   Tsakris, A ^a   Legakis, N J ^a   Routsias, John G ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c G GENNIMATAS GENERAL HOSPITAL   (Greece)

^d ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^e UNIVERSITY GENERAL HOSPITAL OF PATRAS   (Greece)

^f General Hospital of Larisa   (Greece)

^g UNIVERSITY HOSPITAL OF IRAKLION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; BLOOD DONOR; COXSACKIE VIRUS B; COXSACKIE VIRUS B3; ENZYME LINKED IMMUNOSORBENT ASSAY; GEOGRAPHIC DISTRIBUTION; GREECE; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PERICARDITIS; SEROPREVALENCE; STATISTICAL ANALYSIS; SUDDEN DEATH; VIRUS MYOCARDITIS;

ADULT; AMINO ACID SEQUENCE; ANTIBODIES, VIRAL; COXSACKIEVIRUS INFECTIONS; DIABETES MELLITUS, TYPE 1; ENTEROVIRUS B, HUMAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; GREECE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MOLECULAR SEQUENCE DATA; SEROEPIDEMIOLOGIC STUDIES;

COXSACKIEVIRUS; ENTEROVIRUS; HUMAN ENTEROVIRUS B;

EID: 34247210246     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2006.0085     Document Type: Article

References (27)

1. Ahn J, Joo CH, Seo I, Kim D, Kim YK, and Lee H: All CVB serotypes and clinical isolates induce irreversible cytopathic effects in primary cardiomyocytes. J Med Virol 2005;75:290-294.
2. Andreoletti L, Hober D, Hober-Vandenberghe C, Fajardy I, Belaich S, Lambert V, Vantyghem MC, Lefebvre J, and Wattre P: Coxsackie B virus infection and beta cell autoantibodies in newly diagnosed IDDM adult patients. Clin Diagn Virol 1998;9:125-133.
3. Bartsocas CS: The Greek contribution to diabetes research. Diabetes Metab Res Rev 1999;15:362-372.
4. Bartsocas CS, Dacou-Voutetakis C, Damianaki D, Karayanni CH, Kassiou C, Qadreh A, Theodoridis CH, Tsoka H, and Green A: Epidemiology of childhood IDDM in Athens: Trends in incidence for the years 1989-1995. Eurodiab ACE G1 Group. Diabetologia 1998;41:245-246.
5. Chadwick DR: Viral meningitis. Br Med Bull 2006;75/76:1-14.
6. Dacou-Voutetakis C, Karavanaki K, and Tsoka-Gennatas H: National data on the epidemiology of IDDM in Greece: Cases diagnosed in 1992. Hellenic Epidemiology Study Group. Diabetes Care 1995;18:552-554.
7. Fields BN, ed.: In: Fields Virology. Raven Press, New York, 1990, p. 578.
8. Grumbach IM, Heim A, Pring-Akerblom P, Vonhof S, Hein WJ, Muller G, and Figulla HR: Adenoviruses and enteroviruses as pathogens in myocarditis and dilated cardiomyopathy. Acta Cardiol 1999;54:83-88.
9. Haverkos HW, Battula N, Drotman DP, and Rennert OM: Enteroviruses and type 1 diabetes mellitus. Biomed Pharmacother 2003;57:379-385.
10. Hosenpud JD, Novick RJ, Bennett LE, Keck BM, Fiol B, and Daily OP: The Registry of the International Society for Heart and Lung Transplantation: Thirteenth official report - 1996. J Heart Lung Transplant 1996;15:655-674.
11. Jun HS, and Yoon JW: A new look at viruses in type 1 diabetes. Diabetes Metab Res Rev 2003;19:8-31.
12. Kandolf R, Klingel K, Zell R, Canu A, Fortmuller U, Hohenadl C, Albrecht M, Reimann BY, Franz WM, Heim A, et al.: Molecular mechanisms in the pathogenesis of enteroviral heart disease: Acute and persistent infections. Clin Immunol Immunopathol 1993;68:153-158.
13. Kearney MT, Cotton JM, Richardson PJ, and Shah AM: Viral myocarditis and dilated cardiomyopathy: Mechanisms, manifestations, and management. Postgrad Med J 2001;77:4-10.
14. Kim KS, Hufnagel G, Chapman NM, and Tracy S: The group B coxsackieviruses and myocarditis. Rev Med Virol 2001;11:355-368.
15. Liu Z, Yuan J, Yanagawa B, Qiu D, McManus BM, and Yang D: Coxsackievirus-induced myocarditis: New trends in treatment. Expert Rev Anti Infect Ther 2005;3:641-650.
16. Lu JC, Koay KW, Ramers CB, and Milazzo AS: Neonate with coxsackie B1 infection, cardiomyopathy and arrhythmias. J Natl Med Assoc 2005;97:1028-1030.
17. Maier R, Krebs P, and Ludewig B: Immunopathological basis of virus-induced myocarditis. Clin Dev Immunol 2004;11:1-5.
18. Martino TA, Liu P, and Sole MJ: Viral infection and the pathogenesis of dilated cardiomyopathy. Circ Res 1994;74:182-188.
19. Minor P: Enteroviruses. In: Principles and Practice of Clinical Virology. Zuckerman A, Banatvala J, and Pattison J, eds. John Wiley & Sons, New York, 1994, pp. 417-439,
20. Pozzetto B, Gaudin OG, Lucht FR, Hafid J, and Ros A: Detection of immunoglobulin G, M, and A antibodies to enterovirus structural proteins by immunoblot technique in echovirus type 4-infected patients. J Virol Methods 1990;29:143-155.
21. Rezig D, Ben Yahia A, Ben Abdallah H, Bahri O, and Triki H: Molecular characterization of coxsackievirus B5 isolates. J Med Virol 2004;72:268-274.
22. Roivainen M, Knip M, Hyoty H, Kulmala P, Hiltunen M, Vahasalo P, Hovi T, and Akerblom HK: Several different enterovirus serotypes can be associated with prediabetic autoimmune episodes and onset of overt IDDM. Childhood Diabetes in Finland (DiMe) Study Group. J Med Virol 1998;56:74-78.
23. Shulman LM, Handsher R, Yang CF, Yang SJ, Manor J, Vonsover A, Grossman Z, Pallansch M, Mendelson E, and Kew OM: Resolution of the pathways of poliovirus type 1 transmission during an outbreak. J Clin Microbiol 2000;38:945-952.
24. Spanakis N, Manolis EN, Tsakris A, Tsiodras S, Panagiotopoulos T, Saroglou G, and Legakis NJ: Coxsackievirus B3 sequences in the myocardium of fatal cases in a cluster of acute myocarditis in Greece. J Clin Pathol 2005;58:357-360.
25. Steinberg W, and Tenner S: Acute pancreatitis. N Engl J Med 1994;330:1198-210.
26. Whitton JL: Immunopathology during coxsackievirus infection. Springer Semin Immunopathol 2002;24:201-213.
27. Zaoutis T, and Klein JD: Enterovirus infections. Pediatr Rev 1998;19:183-191.